GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 229 filers reported holding GENMAB A/S in Q3 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,769,000 | -3.3% | 117,306 | -2.2% | 1.40% | +5.3% |
| Q2 2022 | $3,897,000 | -10.0% | 119,956 | +0.2% | 1.33% | +3.3% |
| Q1 2022 | $4,330,000 | -8.4% | 119,681 | +0.2% | 1.29% | -0.5% |
| Q4 2021 | $4,727,000 | -11.1% | 119,495 | -1.8% | 1.30% | +2.3% |
| Q3 2021 | $5,315,000 | -6.8% | 121,635 | -12.9% | 1.27% | -3.4% |
| Q2 2021 | $5,700,000 | +21.9% | 139,610 | -2.0% | 1.31% | +14.8% |
| Q1 2021 | $4,677,000 | -5.8% | 142,460 | +16.6% | 1.14% | -12.5% |
| Q4 2020 | $4,967,000 | +8.0% | 122,150 | -2.8% | 1.30% | -4.3% |
| Q3 2020 | $4,600,000 | +2.6% | 125,650 | -5.0% | 1.36% | -6.6% |
| Q2 2020 | $4,484,000 | +45.3% | 132,325 | -9.1% | 1.46% | +25.5% |
| Q1 2020 | $3,085,000 | -8.1% | 145,575 | -3.1% | 1.16% | -1.4% |
| Q4 2019 | $3,356,000 | +6.9% | 150,300 | -3.0% | 1.18% | +16.7% |
| Q3 2019 | $3,140,000 | – | 155,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |